{"name":"Satellos Bioscience, Inc.","slug":"satellos-bioscience-inc","ticker":"","exchange":"","domain":"satellos.com","description":"Satellos Bioscience, Inc. is a biotechnology company focused on developing novel therapies for muscle diseases. The company's lead candidate, SAT-3247, is currently in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxOeUk4cF8xM05qWTlDSkFRUHI4ZjdhbFMzX3VGdGlxWl9iUnpMOWtWWFFDTGJJblZyZURDcnVZNzFEYzEySUh1SGF5YWJfS3p2WmxJQy0yS1ZwTy1rMTlkQTlIRnN0c3F6MUZLV015N1hVREJMSzNpMGVXbGVJQWp4NWpRYkhQemItMjk3QnlIaFBvUHNuZ2k5RWZXUlVvT0d3RzM5Ty0tTTkwRldVcWE4dmYxZnYtazZPcGpTUVBfVnctajEyQ3dvUDllWTNENHVINVdFak1CWnJxX1I1dWZOV1Riak1GNGNOYXJONzlGNXdwZTEtb2w5TnN2VQ?oc=5","date":"2026-03-10","type":"trial","source":"Investing News Network","summary":"Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference - Investing News Network","headline":"Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical &","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOWGxSSVJyRGE3YVMwVEtLSGY3Z0ptRVA1Y0R6UDZsWnpZS0pUQmFTOV9lVHBSR3puOGxiVTJmZU43UGRzM2dPY0FzTV9lTkxqNWFmZmgwZi1fb0MyT29sM3VrU0ZMb1hwQ01KTmo2Y0hZRGEtTy1TNXM1YU4tcndQenBVYWllVER2Wm1EeE5lbTJ6VlN2N1lnV2tLZ0E3UXEwRVk1Sk5vNk9sUXdtTEFieHZNbndwUVE?oc=5","date":"2026-01-29","type":"pipeline","source":"Contract Pharma","summary":"Satellos Bioscience Taps Antoinette Paone as Chief Development Officer - Contract Pharma","headline":"Satellos Bioscience Taps Antoinette Paone as Chief Development Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPVnVoVXFWczJiVm12Si1IeUtkLW1EZVVkeW5nS2VUYzZhS1VKbmNaM2xvSWlTUjM0dFl2bC04OFRrZ0RGZzBoOXFvdUFZV0hpZmJSaWoxLUZsSG1HU3gyT1FhTzFCUUg4MUtEQTZ0TnJxaFRrNlF1dmFnb1FrU2Jka1Ftd0xsT0FhMUp2OGQ4QVJ5NnVOOU91Rzh0Tzk5eEgxWUpFYzBfTUIxcXBNdWlVY2hXVUxqa3lZOEZvX1lWUHR5d3dUaTRBMC00dEtldlFySS1OTUVtMG1tc0o4VlcyNDgxdUhwZw?oc=5","date":"2026-01-29","type":"regulatory","source":"Business Wire","summary":"Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs - Business Wire","headline":"Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTFBKWHNVdHhMZ0dMT0tpT2dyMnp3R0ZPRnZaZm5QVEI4R2FfY211TDBzOGdUTk1aaHp0Q2pVYXBGZnlyTGZ2c1ZhbVZPQmdLVU5IOG9FQWY1ZC1hTjR4MWhKRm11UVdlZC1OR21iTTluOA?oc=5","date":"2026-01-05","type":"pipeline","source":"Investing News Network","summary":"Discover the Top 4 Canadian Pharma Stocks of 2025 - Investing News Network","headline":"Discover the Top 4 Canadian Pharma Stocks of 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxQakxrTU5POUd1UW9ZdUhXbmZ0MnNTdUU4cS1CbUYwd21OOU0zeU5RSzVsQ0s5UDFReHF6bmtLNzVDRTdyUTRzWUpDMGp6YzJPallENkpSREVPY3Uzci1wUV9WS1p0ZFFBeThDcjBFZVozajY5WGRDLXVwYTlhMTMweGI2Xy1LWW03SzVvU3RRSlRaTmFBYUU4U1E3ZkVfbUVvZG52RkFVRDVHXy00ZElFd1VvOXN2S1cwLTRvczJLNVFaZjNCZ20wQ25LOVN0MFBYU1BaVHF1ZmlGWEhHa29oMm9LeUlVdWFzUjBPbTZYazlkekxadklz?oc=5","date":"2025-11-14","type":"earnings","source":"Business Wire","summary":"Satellos Reports Third Quarter 2025 Results and Announces Appointment of Mark Nawacki to Board of Directors - Business Wire","headline":"Satellos Reports Third Quarter 2025 Results and Announces Appointment of Mark Nawacki to Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOaVUzMnJQS0pXb2RLWlZJbzNHWlNsWF81UnBkN1JiaE1EYUl2NnFacDlMZzJIN0ZtSDQ1aUxVTmVvTGRPU0M5dU8zbjc5YkpzckRUNEpTbnJqY21aNDlGUTBJT3dBLTJMRWMxSi1kWDE3dWVkeUdZZTNKZl9KRFRzcldNQ20zZy1CTlFyNWl1SUx2UE9vU0x3ZE5wYm0tc0FkUl84RHV3?oc=5","date":"2025-07-16","type":"pipeline","source":"Contract Pharma","summary":"Satellos Appoints Wildon Farwell as Chief Medical Officer - Contract Pharma","headline":"Satellos Appoints Wildon Farwell as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE41SThHbElTN2dTZjBwSXFSSTF0dFhwMTM4SF9QMU1HRVRTaHprc2szNHFGZy1WV3ZyeGpHcFBqTVpueTFvaEVOanhrU2J0alotZ0FGLQ?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"NGENF Stock Price, News & Analysis | Nervgen Pharma - Stock Titan","headline":"NGENF Stock Price, News & Analysis | Nervgen Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE1IczJZcWJBa0RkZ3dlSGdUTWpMTXdnQkxQRnhkMEZ2aGY4U2pXNGVueWRCVDU0WHRtRXdsTWJYM2F1Z2hicm9VVzJHZUd6bF9vUTBqeEpwc2MyV2JhYjdKdQ?oc=5","date":"2024-05-06","type":"trial","source":"Yahoo! Finance Canada","summary":"Satellos Bioscience Inc. (MSCL.TO) Stock Historical Prices & Data - Yahoo! Finance Canada","headline":"Satellos Bioscience Inc. (MSCL.TO) Stock Historical Prices & Data - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE1jejRwTHAxQnFJR0NTSEhxUVdFamY3VTNxcEJnMWVKcEVzaEdScmRfYVUxajlydE4zeTZKRWRrMWc4T0g1N1ZCR3VYU0pxTDZ1a1F5MmlB?oc=5","date":"2024-02-17","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Satellos Bioscience Inc. (MSCL.TO) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Satellos Bioscience Inc. (MSCL.TO) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE43NzJtYjZhMW1iZXFpc3RpZUFCQVlWWHZoVHpBbGhmcTF5ZXZac1ZEMUZWb3BRMG1mc2l3aWY1UWluZjNiZkY0c3FLNklNX2ZJakd5NEhpY0s?oc=5","date":"2024-02-16","type":"pipeline","source":"TradingView","summary":"MSCL Stock Price and Chart — TSX:MSCL - TradingView","headline":"MSCL Stock Price and Chart — TSX:MSCL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNREYwcGJfazlCRkh3T1dwc3BpN1JCZkc1ZjR1WDA3MWNEZ29BRUNUWE10R0lHRTcyZkt5SF9HV1ZOcmZUWXhGWlpUbUFPdFNlWTNMQXg3SGs5OFFVY3c1SWRieHE3NmdJUVRwUFRmbHMyNkJSZ0Etbk1Udjd0UHNESERtMzg3OWdxMmI5dl9WV2ZHem9iYk1EMjRhS3QtX1U3dDJYVEJmN2RWckpEWXY4ZW1QSGZ2VERfN3BIUXFaSVVuYmROR2dxTUZWeTVPUVJJZ28tMkhZLWVFVVpjRG5wdUl3a3JHal96Zkk3Z3pSWEIwbkNZdHVwWA?oc=5","date":"2022-10-06","type":"deal","source":"TMX Newsfile","summary":"Satellos Bioscience Inc. Announces Licensing of Formulation Technology and Expanded Collaboration with NW PharmaTech Ltd. - TMX Newsfile","headline":"Satellos Bioscience Inc. Announces Licensing of Formulation Technology and Expanded Collaboration with NW PharmaTech Ltd","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxQQmZ1bkpoak50VHh1Sms5eXB0Qm0yX2tZTjRqOXNOelFsSXVWX1hyN2lIZmIzV1V4MlhMZ3dRWWotZS0ySGpKYk5UVVY1R25oLUF0cXUwU0MyOFZCX0xTeGF2Z00xdG1nbTJNVHB2STFOaTBPN2x1SGRaMktoY09Sc2dzMTJjWFZDLS0tY1RMZkFBUzNtT1BpcmxHbjhnNUliOTkzZnluMTV5U3EtZEJ3a2FmTm9tYWJDeDZxNTZNWnJiV1dMck8zb0oySm1EUW1CQkhrOXJ3RWhDZFhXTG56Q2dR?oc=5","date":"2022-09-28","type":"pipeline","source":"TMX Newsfile","summary":"Satellos Bioscience Inc. Announces the Appointment of Philip D. Lambert, Ph.D, as Chief Technology Officer - TMX Newsfile","headline":"Satellos Bioscience Inc. Announces the Appointment of Philip D. Lambert, Ph.D, as Chief Technology Officer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}